全文获取类型
收费全文 | 4656篇 |
免费 | 276篇 |
国内免费 | 650篇 |
出版年
2024年 | 4篇 |
2023年 | 77篇 |
2022年 | 101篇 |
2021年 | 127篇 |
2020年 | 110篇 |
2019年 | 148篇 |
2018年 | 117篇 |
2017年 | 115篇 |
2016年 | 117篇 |
2015年 | 139篇 |
2014年 | 230篇 |
2013年 | 313篇 |
2012年 | 185篇 |
2011年 | 246篇 |
2010年 | 207篇 |
2009年 | 280篇 |
2008年 | 287篇 |
2007年 | 270篇 |
2006年 | 294篇 |
2005年 | 276篇 |
2004年 | 216篇 |
2003年 | 211篇 |
2002年 | 214篇 |
2001年 | 202篇 |
2000年 | 141篇 |
1999年 | 140篇 |
1998年 | 99篇 |
1997年 | 94篇 |
1996年 | 77篇 |
1995年 | 58篇 |
1994年 | 76篇 |
1993年 | 62篇 |
1992年 | 65篇 |
1991年 | 43篇 |
1990年 | 22篇 |
1989年 | 18篇 |
1988年 | 23篇 |
1987年 | 9篇 |
1986年 | 9篇 |
1985年 | 36篇 |
1984年 | 29篇 |
1983年 | 14篇 |
1982年 | 22篇 |
1981年 | 17篇 |
1980年 | 11篇 |
1979年 | 21篇 |
1978年 | 7篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1972年 | 1篇 |
排序方式: 共有5582条查询结果,搜索用时 499 毫秒
71.
以肠炎沙门氏菌脂多糖为抗原,用酶标法测定Vi多糖菌苗免疫血清的抗LPS抗体。各Vi多糖菌苗组免疫后1月,6月的抗LPS水平均显著高于免前(P<0.0001),对照组无显著差异(p>0.1)。两30μg菌苗组抗LPS阳转率均约为15%。提纯Vi多糖菌苗所含的微量伤寒LPS,也可能为接种者提供一定的保护作用。 相似文献
72.
Maurizi G Bossù P Boraschi D Ulisse E Tagliabue A Ruggiero P 《Biotechnology and bioengineering》1995,48(3):197-200
A recombinant strain of Bacillus subtilis engineered for endocellular expression of human interleukin-1 receptor antagonist (IL-Ira) was subjected to sporulation. The recombinant protein was recovered from the sporulation supernatant in quantities, purity, and activity comparable with those obtained from a traditional cell lysate. Thus, exploitation of this natural mechanism of autolysis could overcome problems of intact protein recovery related to the cell disruption step. (c) 1995 John Wiley & Sons, Inc. 相似文献
73.
Jean L. Sarcich H. David Fischer Merrill S. Babcock Joseph W. Leone Alfredo G. Tomasselli 《Journal of Protein Chemistry》1995,14(2):73-80
Cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl ester from high- and low-density lipoproteins to triglyceride-rich lipoproteins, and reciprocally mediates triglyceride transfer. The gene for cynomolgus monkey CETP was expressed in serum-free CHO culture with 2g/ml insulin as its only exogenous protein supplement. Cell growth was facilitated by immobilizing the CHO cells in alginate beads. Recombinant CETP (rCETP) was purified 176-fold with a three-step protocol resulting in a 60% final yield as measured by a fluorescent CETP activity assay. Typically, 3.4 mg of rCETP was purified from 1700 ml of media by affinity-gel chromatography involving Reactive Red 120 (RR120) followed by concanavalin A Sepharose 4B and rechromatography on RR120. SDS-PAGE shows a single broad band ofM
r
, ranging from 68,000 to 74,000 which immunoreacts in Western blot analysis. Amino acid analysis and protein sequencing of the purified protein agree with the theoretical amino acid composition and sequence of cynomolgus CETP. 相似文献
74.
75.
During the production by mammalian cells of recombinant factor VIII from which the B domain was deleted (rFVIII), proteolytic
cleavages in the C-terminal part of the heavy chain were observed (Kjalke et al., 1995). By radioactive pulse labelling it
was investigated whether the cleavages took place inside the cells during protein synthesis or after release in the medium.
The rFVIII-producing CHO (Chinese hamster ovary) cells were cultured in the presence of 35S-methionine and then the cell lysate and the conditioned media were immunoprecipitated and analyzed by electrophoresis. By
pulse labelling and chasing for various time periods, it was shown that the cleavages only took place after secretion of the
protein from the cells. Adding cell lysate to uncleaved rFVIII caused cleavage of the heavy chain, as seen by loss of binding
to a monoclonal antibody specific for intact rFVIII, indicating that the cleavage was performed by proteinase(s) released
from the lysed cells. By incubating intact rFVIII with the multicatalytic proteinase (proteasome) present in cytoplasm and
nucleus of eukaryotic cells, loss of binding to the monoclonal antibody was observed. This indicates that the multicatalytic
proteinase, released from lysed rFVIII producing cells, could be responsible for the cleavage of rFVIII. Among several protease
inhibitors tested, only bacitracin was found to diminish the extent of cleavage. Phosphatidylserine also protected rFVIII
against cleavage, probably by binding to rFVIII.
This revised version was published online in July 2006 with corrections to the Cover Date. 相似文献
76.
Crystal structure of a non-toxic mutant of heat-labile enterotoxin, which is a potent mucosal adjuvant. 总被引:1,自引:0,他引:1 下载免费PDF全文
F. van den Akker M. Pizza R. Rappuoli W. G. Hol 《Protein science : a publication of the Protein Society》1997,6(12):2650-2654
Two closely related bacterial toxins, heat-labile enterotoxin (LT-I) and cholera toxin (CT), not only invoke a toxic activity that affects many victims worldwide but also contain a beneficial mucosal adjuvant activity that significantly enhances the potency of vaccines in general. For the purpose of vaccine design it is most interesting that the undesirable toxic activity of these toxins can be eliminated by the single-site mutation Ser63Lys in the A subunit while the mucosal adjuvant activity is still present. The crystal structure of the Ser63Lys mutant of LT-I is determined at 2.0 A resolution. Its structure appears to be essentially the same as the wild-type LT-I structure. The substitution Ser63Lys was designed, based on the wild-type LT-I crystal structure, to decrease toxicity by interfering with NAD binding and/or catalysis. In the mutant crystal structure, the newly introduced lysine side chain is indeed positioned such that it could potentially obstruct the productive binding mode of the substrate NAD while at the same time its positive charge could possibly interfere with the critical function of nearby charged groups in the active site of LT-I. The fact that the Ser63Lys mutant of LT-I does not disrupt the wild-type LT-I structure makes the non-toxic mutant potentially suitable, from a structural point of view, to be used as a vaccine to prevent enterotoxigenic E. coli infections. The structural similarity of mutant and wild-type toxin might also be the reason why the inactive Ser63Lys variant retains its adjuvant activity. 相似文献
77.
The maltose binding protein (MBP or MalE) of Escherichia coli is the periplasmic component of the transport system for malto-oligosaccharides. It is used widely as a carrier protein for the production of recombinant fusion proteins. The melting of recombinant MBP was studied by differential scanning and titration calorimetry and fluorescence spectroscopy under different solvent conditions. MBP exhibits a single peak of heat absorption with a delta(Hcal)/delta(HvH) ratio in the range of 1.3-1.5, suggesting that the protein comprises two strongly interacting thermodynamic domains. Binding of maltose resulted in elevation of the Tm by 8-15 degrees C, depending of pH. The presence of ligand at neutral pH, in addition to shifting the melting process to higher temperature, caused it to become more cooperative. The delta(Hcal)/delta(HvH) ratio decreased to unity, indicating that the two domains melt together in a single two-state transition. This ligand-induced merging of the two domains appears to occur only at neutral pH, because at low pH maltose simply stabilized MBP and did not cause a decrease of the delta(Hcal)/delta(HvH) ratio. Binding of maltose to MBP is characterized by very low enthalpy changes, approximately -1 kcal/mol. The melting of MBP is accompanied by an exceptionally large change in heat capacity. 0.16 cal/K-g, which is consistent with the high amount of nonpolar surface--0.72 A2/g--that becomes accessible to solvent in the unfolded state. The high value of delta Cp determines a very steep delta G versus T profile for this protein and predicts that cold denaturation should occur above freezing temperatures. Evidence for this was provided by changes in fluorescence intensity upon cooling the protein. A sigmoidal cooperative transition with a midpoint near 5 degrees C was observed when MBP was cooled at low pH. Analysis of the melting of several fusion proteins containing MBP illustrated the feasibility of assessing the folding integrity of recombinant products prior to separating them from the MBP carrier protein. 相似文献
78.
The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S. 下载免费PDF全文
J. O. Egan M. Kalafatis K. G. Mann 《Protein science : a publication of the Protein Society》1997,6(9):2016-2027
Factor Va (fVa) is inactivated by activated protein C (APC) by cleavage of the heavy chain at Arg306, Arg506, and Arg679. Site-directed mutagenesis of human factor V cDNA was used to substitute Arg306-->Ala (rfVa306A) and Arg506-->Gln (rfVa506Q). Both the single and double mutants (rfVa306A/506Q) were constructed. The activation of these procofactors by alpha-thrombin and their inactivation by APC were assessed in coagulation assays using factor V-deficient plasma. All recombinant and wild-type proteins had similar initial cofactor activity and identical activation products (a factor Va molecule composed of light and heavy chains). Inactivation of factor Va purified from human plasma (fVaPLASMA) in HBS Ca2+ +0.5% BSA or in conditioned media by APC in the presence of phospholipid vesicles resulted in identical inactivation profiles and displayed identical cleavage patterns. Recombinant wild-type factor Va (rfVaWT) was inactivated by APC in the presence of phospholipid vesicles at an overall rate slower than fVaPLASMA. The rfVa306A and rfVa506Q mutants were each inactivated at rates slower than rfVaWT and fVaPLASMA. Following a 90-min incubation with APC, rfVa306A and rfVa506Q retain approximately 30-40% of the initial cofactor activity. The double mutant, rfVa306A/506Q, was completely resistant to cleavage and inactivation by APC retaining 100% of the initial cofactor activity following a 90-min incubation in the presence of APC. Recombinant fVaWT, rfVa306A, rfVa506Q, and rfVa306A/506Q were also used to evaluate the effect of protein S on the individual cleavage sites of the cofactor by APC. The initial rates of rfVaWT and rfVa306A inactivation in the presence of protein S were unchanged, indicating cleavage at Arg506 is not affected by protein S. The initial rate of rfVa506Q inactivation was increased, suggesting protein S slightly accelerates the cleavage at Arg306. Overall, the data demonstrate high specificity with respect to cleavage sites for APC on factor Va and demonstrate that cleavages of the cofactor at both Arg306 and Arg506 are required for efficient factor Va inactivation. 相似文献
79.
丁酸钠对CHO-EPO工程细胞株rhEPO表达量的影响 总被引:1,自引:0,他引:1
以稳定整合有pEDEPO的CHOEPO工程细胞株为研究对象,在无血清条件下,系统观察了05、10、25和50mmol/L4个浓度的丁酸钠作用于该细胞株的情况,结果表明:丁酸钠对CHOEPO工程细胞的生长有明显的抑制作用;影响CHOEPO工程细胞EPO表达,浓度10mmol/L可提高EPO表达量25倍左右,并可持续较长的一段时间;延缓CHOEPO工程细胞在无血清培养时的细胞脱落;提高CHOEPO工程细胞EPOmRNA水平 相似文献
80.
Construction of a trivalent candidate Shigella vaccine strain with host-vector balanced-lethal system 总被引:1,自引:0,他引:1
A trivalent liveShigella vaccine candidate FSD01 against S.flexneri 2a, S.sonnei and S.dysenteriae I was constructed. This candidate strain was based on the S.flexneri 2a vaccine T32. By homologous recombination exchange, the chromosomalasd gene of T32 was site-specifically inactivated, resulting in the strain unable to grow normally in LB broth, while anotherasd gene of S.mutans was employed to construct an Asd+ complementary vector. This combination ofasd
- host/Asd+ vector formed a balanced-lethal expression system in T32 strain. By use of this system, two important protective antigen
genes coding for S.sonnei Form I antigen and Shiga toxin B subunit were cloned and expressed in T32, which led to the construction of trivalent candidate
vaccine FSD01. Experimental results showed that this strain was genetically stable, but its recombinant plasmid was non-resistant.
Moreover, it was able to effectively express trivalent antigens in one host and induce protective responses in mice against
the challenges of the above threeShigella strains. 相似文献